IJMABHR International Journal of Medical and All Body Health ResearchIJMABHR 2582-8940 Anfo Publication House 238 10.54660/IJMBHR.2024.5.3.55-60 Immunological Response to Toxoplasma IgG in Adult Women: A Review MerieGhufran Mohammed Sadee Department of Medical Laboratory Technologies, Mosul Medical Technical Institute, Northern Technical University, Iraq 2024 5 3 55 60 27062024 05072024 CC BY-NC-SA 4.0

Human Toxoplasma IgG is a serological marker of imported Toxoplasma gondii infection in humans, providing insights into immunoglobulin G (IgG) antibodies against T. gondii. Serological tests are the most widely used tools for the diagnosis of toxoplasmosis. In most laboratories, indirect serological tests such as enzyme-linked immunosorbent assays (ELISA) are performed routinely. The ELISA test is commonly used to detect anti-toxoplasma IgG or IgM antibodies. IgG-anti-Toxoplasma gondii antibodies were determined in 120 adult women, aged between 19-45 years, with no history of pregnancy, using the indirect ELISA method. Of these, 62 women had a negative test for IgG-anti-T. Gondii antibodies and 58 women were positive (48.33%). Positivity was 4 times higher for women aged between 20-29 years. The high positivity in women aged 19 years was statistically irrelevant.

 Toxoplasma gondiAIDSRESPRRs References Carolina de Morais Oliveira-Scussel A, Tatiana Mutão Ferreira P, de Souza Resende R, Molinero Ratkevicius-Andrade C, de Oliveira Gomes A, Carvalho Paschoini M, et al. Association of gestational diabetes mellitus and negative modulation of the specific humoral and cellular immune response against Toxoplasma gondii; c2022. ncbi.nlm.nih.gov Gabriel Mihu A, Alina Lupu M, Nesiu A, Teodora Marti D, Rares Olariu T. Screening for the Detection of Toxoplasma gondii IgG, IgM and IgA in Females of Reproductive Age from Western Romania; c2022. ncbi.nlm.nih.gov Csep A, Ligia Vaida L, Negruțiu BM, Ioana Todor B, Teodora Judea-Pusta C, Buhaș C, et al. Research on demographic, clinical and paraclinical aspects in pregnant women infected with Toxoplasma gondii; c2021. ncbi.nlm.nih.gov Nayeri T, Sarvi S, Daryani A. Effective factors in the pathogenesis of Toxoplasmago ndii; c2024. ncbi.nlm.nih.gov Schlüter D, Barragan A. Advances and Challenges in Understanding Cerebral Toxoplasmosis; c2019. [PDF]. Delgado Betancourt E, Hamid B, T Fabian B, Klotz C, Hartmann S, Seeber F. From Entry to Early Dissemination-Toxoplasma gondii's Initial Encounter With Its Host; c2019. [PDF] Shoukat T, Ayub Awan U, Mahmood T, Sohail Afzal M, Wasif S, Ahmed H, et al. Epidemiology of Toxoplasmosis among the Pakistani Population: A Systematic Review and Meta-Analysis; c2022. ncbi.nlm.nih.gov Voyiatzaki C, Dareios Zare Chormizi A, E Tsoumani M, Efstathiou A, Konstantinidis K, Chaniotis D, et al. Seroprevalence of Toxoplasma gondii among HIV Positive Patients under Surveillance in Greek Infectious Disease Units: A Screening Study with Comparative Evaluation of Serological Methods; c2024. ncbi.nlm.nih.gov Marianny Ferreira Nascimento Barbosa de Souza I, da Silva Siqueira V, da Costa Ribeiro I, Silva Pinto Moraes L, Pereira Gomes do Prado D, Rodrigues Rezende S, et al. Molecular and serological diagnosis of toxoplasmosis: a systematic review and meta-analysis; c2023. ncbi.nlm.nih.gov S Roiko M, LaFavers K, Leland D, Arrizabalaga G. Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity; c2018. [PDF] Geanina Mocanu A, Liana Stoian D, Lidia Craciunescu E, Mihaela Ciohat I, Catalin Motofelea A, Bogdan Navolan D, et al. The Impact of Latent Toxoplasma gondii Infection on Spontaneous Abortion History and Pregnancy Outcomes: A Large-Scale Study; c2022. ncbi.nlm.nih.gov Motoi S, Bogdan Navolan D, Malita D, Ciohat I, Nemescu D, Manciuc C, et al. A decreasing trend in toxoplasma gondii seroprevalence among pregnant women in Romania - results of a large scale study; c2020. ncbi.nlm.nih.gov Abdelgadir Shaaeldin M, A Khieri S, Nasralla K, Saadia Z, Alkhatim Alsammani M. Toxoplasmosis in Pregnancy: Diagnosis, Risk Factors, and Management; c2018. [PDF] Soberón Felín M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al. Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview; c2022. ncbi.nlm.nih.gov. A Khan I, R Green W, H Kasper L, A Green K, D Schwartzman J. Immune CD8+ T Cells Prevent Reactivation of Toxoplasma gondii Infection in the Immunocompromised Host. [PDF]; c1999. Brydak-Godowska J, Moneta-Wielgoś J, Kęcik D, Karol International Journal of Medical and All Body Health Research www.allmedicaljournal.com Borkowski P. Management of Toxoplasmic Retinochoroiditis during Pregnancy, Postpartum Period and Lactation: Clinical Observations; c2015. ncbi.nlm.nih.gov Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.